Teva to Acquire Emalex, Adds NDA-Ready Neuroscience Drug
Teva Pharmaceuticals has signed a definitive agreement to acquire Emalex Biosciences for $700 million upfront, with up to $200...
Avicanna on U.S. Cannabis Rescheduling & New Science Update
The U.S. Department of Justice and Drug Enforcement Administration have moved to reschedule certain cannabinoid-based products from Schedule I...
Novo Nordisk Presents New Data on Wegovy, Women’s Obesity
Novo Nordisk will bring 52 abstracts to the European Congress on Obesity (ECO) in Istanbul, May 12–15, spotlighting its...
Study Reveals Under-recognised Genetic Driver for Adult FSGS
Purespring Therapeutics has published a population modeling study in Kidney International Reports indicating that pathogenic NPHS2 variants are a...
Plus Therapeutics Secures Blue Shield Coverage for CNSide Assay
CNSide Diagnostics, a subsidiary of Plus Therapeutics, secured payer coverage from Blue Shield of California for its CNSide Cerebrospinal...
Organogenesis Delivers Complete Renu® Biologics Application
Organogenesis has completed a rolling Biologics License Application to the FDA for Renu, a cryopreserved amniotic suspension allograft for...
Mesoblast Hits Recruitment Target for Chronic Back Pain Trial
Mesoblast has completed enrollment in its pivotal Phase 3 trial of rexlemestrocel-L for chronic low back pain due to...
Novartis Q1 Growth Surges; 2026 Forecast Reaffirmed
Novartis opened 2026 with a mixed first quarter: net sales declined 5% at constant currency and core operating income...
Siren Biotech Publishes Foundational AAV Immuno-Gene Data
Siren Biotechnology has published its first peer-reviewed data in Molecular Therapy Oncology on a universal AAV immuno-gene therapy platform...
Exparel Data: Breakthrough in Lowering Opioid Use & Costs
Pacira BioSciences reported new real-world evidence showing its long-acting local anesthetic, EXPAREL (bupivacaine liposome injectable suspension), was associated with...